Veana S First Productvt 101Is An Orally Bioavailable Anti Cancer Agent That Selectively Attack And Destroy The Energy Powerhousesmitochondriaof Cancer Cells In A Fashion That Subsequently Stimulates The Immune System Vt 101 Is Currently In A Dose Escalating Phase 1B Clinical Trial For Stage Iv Breast Cancer Patients Veana S Therapeutic Platform Can Be Combined With Other Forms Of Immunotherapy To Further Improve Anti Tumor Activity
No conferences found for this company.
| Company Name | Veana Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
